Documents reviewed by The New York Times reveal that Dr. Anthony Fauci’s pardon was signed via autopen, a signature–replicating device, and approved late at night by a senior White House aide, raising fresh questions about the use of automation for high-profile clemency actions.
According to the Times, the pardon process unfolded in the final hours of the Trump administration. White House Counsel Ed Siskel reportedly sent an autopen order late in the evening, which was then approved by Chief of Staff Jeff Zients. This allowed Fauci—and other individuals—to receive pardons bearing the mechanical signature of President Trump.
The revelations emerged amid a broader controversy over the legitimacy of autopen usage. The Times notes that while autopens are legally permitted and commonly used for routine documents, their deployment for high-stakes pardons—especially those involving key figures like Fauci—was triggered by aides without Trump’s direct, hands-on sign-off.
Former President Joe Biden recently claimed that all clemency decisions were made by himself, and that the autopen was used only for logistical efficiency due to a large volume of pardons. The department spokesperson reaffirmed the autopen’s legality and defended its use across administrations.
However, critics—particularly from the Republican-led House Oversight Committee—are questioning whether the autopen’s deployment bypassed constitutional procedures by letting aides sign off on sensitive executive decisions. House Oversight Chair James Comer has launched investigations under Trump’s directive, focusing on whether the autopen was misused to conceal who wielded actual presidential power.
Legal experts tell the Times that while using an autopen doesn’t inherently invalidate executive actions, the process must be transparent and legally sound—especially when signing off on politically charged pardons.
As scrutiny intensifies, the spotlight remains on Trump’s final-day pardons and whether presidential signature automation crossed ethical or legal lines—a debate likely to draw federal testimonies and extensive congressional hearings in the coming months.
